SCHEMBL6002428

SCHEMBL6002428

CCc1scc2c(Cl)cccc12

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 4/20 0.44
CYP2A6 P11509 3/20 0.44
NR4A2 P43354 1/20 0.36
KDM4E B2RXH2 3/20 0.33
LMNA P02545 2/20 0.33
ALDH1A1 P00352 1/20 0.33
DAO P14920 1/20 0.32
TSHR P16473 2/20 0.32
MEN1 O00255 1/20 0.32
TP53 P04637 1/20 0.32
CYP3A4 P08684 1/20 0.32
CYP2C19 P33261 1/20 0.32
KMT2A Q03164 1/20 0.32
TDP1 Q9NUW8 1/20 0.32
NOTUM Q6P988 1/20 0.32
L3MBTL1 Q9Y468 1/20 0.31
ESR1 P03372 1/20 0.31
POLB P06746 1/20 0.30
SMN1; SMN2 Q16637 1/20 0.30
AHR P35869 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2094377 0.81 CYP1A2 (0.44) CYP1A2CYP2A6NR4A2DAOSMN1; SMN2
SCHEMBL2093780 0.74 CYP1A2 (0.50) CYP1A2CYP2A6NR4A2KDM4ELMNA
SCHEMBL2090259 0.73 CYP1A2 (0.36) CYP1A2CYP2A6NR4A2KDM4EALDH1A1
SCHEMBL6003393 0.72 ALDH1A1 (0.36) CYP1A2CYP2A6KDM4EALDH1A1TSHR
SCHEMBL2093776 0.71 CYP1A2 (0.52) CYP1A2CYP2A6NR4A2LMNAALDH1A1
SCHEMBL2090417 0.69 CYP2A6 (0.38) CYP1A2CYP2A6KDM4ELMNAALDH1A1
SCHEMBL6002962 0.68 CYP1A2 (0.38) CYP1A2CYP2A6KDM4ELMNAALDH1A1
SCHEMBL12770134 0.67 CYP1A2 (0.59) CYP1A2CYP2A6NR4A2KDM4ELMNA
SCHEMBL28118419 0.66
SCHEMBL29629127 0.65 CYP1A2 (1.00) CYP1A2CYP2A6NR4A2KDM4ELMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1678185-A1 2,3-DIHYDRO-6-NITROIMIDAZO [2,1-B] OXAZOLE COMPOUNDS FOR THE TREATMENT OF TUBERCULOSIS OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2006-07-12 EP disclosed
WO-2005042542-A1 2,3-DIHYDRO-6-NITROIMIDAZO (2,1-B) OXAZOLE COMPOUNDS FOR THE TREATMENT OF TUBERCULOSIS OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2005-05-12 WO disclosed